The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1
Open accessAbstract
Pseudomonas aeruginosa strains are less susceptible to tigecycline (previously GAR-936; MIC, 8 μg/ml) than many other bacteria (P. J. Petersen, N. V. Jacobus, W. J. Weiss, P. E. Sum, and R. T. Testa, Antimicrob. Agents Chemother. 43:738-744, 1999). To elucidate the mechanism of resistance to tigecycline, P. aeruginosa PAO1 strains defective in the MexAB-OprM and/or MexXY (OprM) efflux pumps were tested for susceptibility to tigecycline. Increased susceptibility to tigecycline (MIC, 0.5 to 1 μg/ml) was specifically associated with loss of MexXY. Transcription of mexX and mexY was also responsive to exposure of cells to tigecycline. To test for the emergence of compensatory efflux pumps in the absence of MexXY-OprM, mutants lacking MexXY-OprM were plated on medium containing tigecycline at 4 or 6 μg/ml. Resistant mutants were readily recovered, and these also had decreased susceptibility to several other antibiotics, suggesting efflux pump recruitment. One representative carbenicillin-resistant strain overexpressed OprM, the outer membrane channel component of the MexAB-OprM efflux pump. The mexAB-oprM repressor gene, mexR , from this strain contained a 15-bp in-frame deletion. Two representative chloramphenicol-resistant strains showed expression of an outer membrane protein slightly larger than OprM. The mexCD-OprJ repressor gene, nfxB , from these mutants contained a 327-bp in-frame deletion and an IS element insertion, respectively. Together, these data indicated drug efflux mediated by MexCD-OprJ. The MICs of the narrower-spectrum semisynthetic tetracyclines doxycycline and minocycline increased more substantially than did those of tigecycline and other glycylcyclines against the MexAB-OprM- and MexCD-OprJ-overexpressing mutant strains. This suggests that glycylcyclines, although they are subject to efflux from P. aeruginosa , are generally inferior substrates for P. aeruginosa efflux pumps than are narrower-spectrum tetracyclines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to the tetracycline-specific transport systems, several MDR efflux pumps like AcrAB-TolC in Enterobacteriaceae and MexAB-OprM in P. aeruginosa (both belonging to the RND family) are able to extrude tetracyclines (including tigecycline) as part of their contribution to multidrug resistance (48, 49).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S., Warrener, P., Hickey, M. J., Brinkman, F. S. L., HUFNAGLE, W. O., Kowalik, D., Mj, L., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,544
Proton-dependent multidrug efflux systems
Paulsen, I. T., Brown, M. H., & Skurray, R. A. (1996) · Microbiological Reviews · doi:10.1128/mr.60.4.575-608.1996 · Cited by 1,089
Lomovskaya, O., Warren, M. S., Lee, A. Y., Galazzo, J. L., Fronko, R. M., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa
Li, X. Z., Nikaido, H., & Poole, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.1948 · Cited by 660
Köhler, T., Michéa-Hamzehpour, M., Henze, U. U., Gotoh, N., Curty, L. K., & Péchère, J.-C. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.2281594.x · Cited by 549
Poole, K., Gotoh, N., Tsujimoto, H., Zhao, Q., 和田明久, Yamasaki, T., Neshat, S., Yamagishi, J., Li, X.-Z., & Nishino, T. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.281397.x · Cited by 443
Chuanchuen, R., Beinlich, K., Hoang, T. T., Becher, A., Karkhoff-Schweizer, R. R., & Schweizer, H. P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.428-432.2001 · Cited by 427
Petersen, P. J., Jacobus, N. V., Weiss, W. J., Sum, P., & TESTA, R. T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.738 · Cited by 413
Self-citationEvidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli
Fralick, J. A. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.19.5803-5805.1996 · Cited by 409
Aires, J., Köhler, T., Nikaido, H., & Plésiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2624 · Cited by 390
Antibiotic Resistance Caused by Gram‐Negative Multidrug Efflux Pumps
Nikaido, H. (1998) · Clinical Infectious Diseases · doi:10.1086/514920 · Cited by 348
Poole, K., Tetro, K., Zhao, Q., Neshat, S., Heinrichs, D. E., & Bianco, N. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2021 · Cited by 324
Contribution of the MexX-MexY-OprM Efflux System to Intrinsic Resistance in Pseudomonas aeruginosa
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2242-2246.2000 · Cited by 279
Ziha-Zarifi, I., Llanes, C., Köhler, T., Péchère, J.-C., & Plésiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.287 · Cited by 276
Expression in Escherichia coli of a New Multidrug Efflux Pump, MexXY, from Pseudomonas aeruginosa
Mine, T., Morita, Y., Kataoka, A., Mizushima, T., & Tsuchiya, T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.415 · Cited by 274
Multidrug Efflux Systems Play an Important Role in the Invasiveness of Pseudomonas aeruginosa
Hirakata, Y., Srikumar, R., Poole, K., Gotoh, N., Suematsu, T., Kohno, S., Kamihira, S., Hancock, R. E. W., & Speert, D. P. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020005 · Cited by 256
Westbrock-Wadman, S., Sherman, D. R., Hickey, M. J., Coulter, S. N., Zhu, Y. Q., Warrener, P., Nguyen, L. Y., Shawar, R. M., Folger, K. R., & Stover, C. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2975 · Cited by 242
Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa
Masuda, N., Sakagawa, E., & Ohya, S. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.645 · Cited by 227
Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa
Masuda, N., & Ohya, S. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.1847 · Cited by 218
Li, X.-Z., Zhang, L., & Poole, K. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.4.433 · Cited by 173
Srikumar, R., Paul, C. J., & Poole, K. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.5.1410-1414.2000 · Cited by 162
Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria.
Lomovskaya, O., & Watkins, W. (2001) · PubMed · Cited by 159
Jellen-Ritter, A., & Kern, W. V. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1467-1472.2001 · Cited by 150
Li, X.-Z. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.6.885 · Cited by 124
Srikumar, R., Li, X., & Poole, K. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.24.7875-7881.1997 · Cited by 121
β-Lactamase Inhibitors Are Substrates for the Multidrug Efflux Pumps of Pseudomonas aeruginosa
Li, X.-Z., Zhang, L., Srikumar, R., & Poole, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.399 · Cited by 114
Dean, C. R., & Poole, K. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.2.317-324.1993 · Cited by 112
Self-citationSchumacher, M. A., & Brennan, R. G. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03039.x · Cited by 101
Saito, K., Hiroshi Yoneyama, C., & Nakae, T. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb08709.x · Cited by 90
nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa
Fukuda, H., Hosaka, M., Iyobe, S., Gotoh, N., Nishino, T., & Hirai, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.790 · Cited by 86
Mao, W., Warren, M. S., Lee, A. Y., Mistry, A., & Lomovskaya, O. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2001-2007.2001 · Cited by 79
Characterization of the Serogroup O11 O-Antigen Locus of Pseudomonas aeruginosa PA103
Dean, C. R., Franklund, C. V., Retief, J., Coyne, M. J., Hatano, K., Evans, D., Pier, G. B., & Goldberg, J. B. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.14.4275-4284.1999 · Cited by 74
Self-citationThe role of the CFTR in susceptibility to Pseudomonas aeruginosa infections in cystic fibrosis
Goldberg, J. B., & Pier, G. B. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01872-2 · Cited by 67
Greenberg, E. P. (2000) · Nature · doi:10.1038/35023203 · Cited by 59
Two Efflux Systems Expressed Simultaneously in Multidrug-Resistant Pseudomonas aeruginosa
Pumbwe, L., & Piddock, L. J. V. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2861-2864.2000 · Cited by 58
Shiba, T., Ishiguro, K., 竹本, 法., Koibuchi, H., & Sugimoto, K. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.20.5872-5877.1995 · Cited by 53
Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa
Jakics, E. B., Iyobe, S., Hirai, K., Fukuda, H., & Hashimoto, H. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.11.2562 · Cited by 52
Okazaki, T. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90386-3 · Cited by 44
Beinlich, K., Chuanchuen, R., & Schweizer, H. P. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10631.x · Cited by 39
[Pseudomonas aeruginosa infection].
Oishi, K. (2003) · PubMed · Cited by 39
Lipopolysaccharide and Virulence of Pseudomonas aeruginosa
Pitt, T. L. (2015) · Antibiotics and chemotherapy/Antibiotica et chemotherapia · doi:10.1159/000417596 · Cited by 11
Cross-Infection with Pseudomonas aeruginosa in Danish Cystic Fibrosis Patients
H�iby, N., & Pedersen, S. S. (2015) · Antibiotics and chemotherapy/Antibiotica et chemotherapia · doi:10.1159/000417613 · Cited by 4
Cited by
Sorted by citations
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Lister, P., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,901
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,648
Multidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,523
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K. P., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,389
Metadata
- Authors
- Dean, C. R., Visalli, M. A., Projan, S. J., Sum, P.-E., & Bradford, P. A.
- Affiliations
- Wyeth (US)
- Corresponding author
- Dean, Charles R.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2003-03
- Volume
- 47
- Issue
- 3
- Pages
- 972-978
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC149306
- OpenAlex
- W2139818499
- Cited by
- 286
- References
- 43
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 13 · 2021: 14 · 2020: 8 · 2019: 9 · 2018: 10 · 2017: 6 · 2016: 14 · 2015: 9 · 2014: 8 · 2013: 10 · 2012: 12
- FWCI
- 9.42
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- tigecycline resistance, Pseudomonas aeruginosa PAO1, efflux pumps, MexXY-OprM, MexCD-OprJ, MexAB-OprM, OprM, mexR, glycylcyclines, tetracycline, doxycycline, minocycline, carbenicillin resistance
- MeSH terms
- Tigecycline, Anti-Bacterial Agents, Bacterial Outer Membrane Proteins, Bacterial Proteins, Culture Media, DNA, Bacterial, Electrophoresis, Polyacrylamide Gel, Microbial Sensitivity Tests, Minocycline, Pseudomonas aeruginosa, Tetracycline Resistance, Tetracyclines, Transcription, Genetic, Blotting, Western, Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review